Altria Group has outperformed the market with a 28.2% total return this year, despite missing the latest earnings estimates. While the firm's smokable segment has not performed too well, the growth in the oral tobacco category and the firm's new NJOY product category indicates meaningful growth potential. Using a dividend discount model, MO's fair value is estimated well-above the current share price, indicating significant upside potential for investors.
Altria's sales fell by 5% last quarter, and things may not get better soon. The stock's payout ratio looks safe, but the company's earnings got a boost from a one-time gain on a sale.
Altria (MO) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Altria Group has seen a strong year with shares up over 26% in 2024, breaking the $50 barrier after years below. Despite risks and negative stigma, MO's Q2 results show a profitable business with strong margins and growth potential in non-combustible products. MO's high dividend yield of 7.68% and commitment to annual dividend increases make it an attractive investment for income-producing portfolios.
Altria's recent price divergence from the broader market is yet another demonstration of its hedging role. The role is very timely judging by the odds of a recession, its Q2 sales data, and the recent price elasticity data of its products. The combination of high yield and low P/E further enhances the potency of its hedging role.
Altria missed expectations in Q2 amid continual revenue challenges in the combustible segment. NJOY momentum, however, remained favorable again. I expect MO to raise its dividend by 4.0% in the third quarter, which would give shares a forward dividend yield of 8%. I am now neutral on valuation, and downgrade shares to hold, given that they have reached my fair value target price of $49 per share.
Altria has delivered relatively strong financial results in Q2, 2024, confirming the notion of a gradually growing business. Yet, considering these data points and the fact that the stock has delivered almost 30% in total returns since the issuance of my initial investment case, I have become less bullish. In this article, I explain the reasons why I have decided to keep my capital in MO, but stopped reinvesting the dividends or increasing the stake here.
Altria (NYSE: MO), the big tobacco company, has a stock that has risen 10% in the last month, while Nasdaq's stock has dropped 3%.
24/7 Insights Altria is a member of the Dividend Kings.
Consumers are smoking fewer and fewer cigarettes. Altria is fighting this headwind well enough with alternative products and stock buybacks.
Altria Group, Inc.'s shares have surged by 15.3% since April, outperforming the S&P 500. Second-quarter financial results showed a decline in revenue and adjusted earnings, with market share erosion continuing. Bright spots included growth in NJOY vaping technology and on! nicotine pouches, but overall weakness persists.
Altria Group NYSE: MO is one of the world's “Big Three” tobacco companies and is in the consumer staples sector. Let's examine the firm's business segments and the state of the cigarette market.